Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

antimicrobial peptide IB-367

Known as: IB-367 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The aim of our study was to evaluate the in vitro activity of IB-367 and its bactericidal effect for Pseudomonas aeruginosa and… Expand
  • table 1
  • table 2
  • table 4
2014
2014
The occurrence of resistance or side effects in patients receiving antifungal agents leads to failure in the treatment of mycosis… Expand
2013
2013
Antimicrobial peptides are known as immunomodulators and antibiotic enhancers. We report that administration of an antimicrobial… Expand
  • table 1
  • figure 1
  • figure 2
2010
2010
The natural antimicrobial cationic peptide protegrin‐1 displays a broad spectrum of antimicrobial activity and rapidly kills… Expand
2009
2009
Taenia solium infections continue being a health problem in undeveloped countries, and few effective control measures against… Expand
  • table 1
  • figure 2
  • figure 4
2007
2007
BACKGROUND Biofilms play an important role in the pathogenesis of several chronic infections and nosocomial infections related to… Expand
2003
2003
Background: Postoperative morbidity in patients with obstructive jaundice remains high because of increased susceptibility to… Expand
2003
2003
The therapeutic efficacy of protegrin peptide IB-367 was investigated in three rat models of septic shock: (i) rats injected… Expand
Highly Cited
2000
Highly Cited
2000
ABSTRACT Although the microflora associated with oral mucositis initiated by cytotoxic therapy is not well characterized, several… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Highly Cited
1999
Highly Cited
1999
OBJECTIVE The purpose of this animal study was to determine whether IB-367, an antimicrobial peptide, is able to ameliorate oral… Expand